Physiological effects of contrast media for use in multidetector row computed tomography

European Journal of Radiology

Volumn 62, Issue SUPPL., 2007, Pages 14-25

  Jakobsen, Jarl A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Contrast media; Contrast induced nephropathy (CIN); Multidetector row computed tomography (MDCT)

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DETECTORS; MEDICAL IMAGING; OPTIMIZATION; PATIENT MONITORING;

CONTRAST INDUCED NEPHROPATHY (CIN); EXTRAVASATION; MULTIDETECTOR ROW COMPUTED TOMOGRAPHY (MDCT); NEPHROTOXIC POTENTIAL;

CONTRAST MEDIA;

CONTRAST MEDIUM;

ARTICLE; IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 34248662406     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.02.021     Document Type: Article

References (99)

1. Almen T. Visipaque-a step forward. A historical review. Acta Radiol Suppl 399 (1995) 2-18
2. Johnson P.T., and Fishman E.K. IV contrast selection for MDCT: current thoughts and practice. AJR Am J Roentgenol 186 (2006) 406-415
3. Maeder M., Klein M., Fehr T., and Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 44 (2004) 1763-1771
4. Brinker J. What every cardiologist should know about intravascular contrast. Rev Cardiovasc Med 4 Suppl. 5 (2003) S19-S27
5. Davidson C., Stacul F., McCullough P.A., et al. Contrast medium use. Am J Cardiol 98 6 Suppl. 1 (2006) 42-58
6. Swanson D., Shetty P., Kastan D., and Rollins N. Angiographic contrast media. In: Swanson D., Chilton H., and Thrall J. (Eds). Pharmaceuticals in medical imaging: radiopaque contrast media radiopharmaceuticals enhancement agents for magnetic resonance imaging and ultrasound (1990), MacMillan Publishing Co., Inc., New York 1-77
7. Pugh N.D., Griffith T.M., and Karlsson J.O. Effects of iodinated contrast media on peripheral blood flow. Acta Radiol Suppl 399 (1995) 155-163
8. Dawson P., Cosgrove D., and Grainger R. Textbook of contrast media (1999), Isis Medical Media Ltd., Oxford
9. Stacul F. Current iodinated contrast media. Eur Radiol 11 (2001) 690-697
10. Nyman U., Almen T., Aspelin P., Hellstrom M., Kristiansson M., and Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 46 (2005) 830-842
11. Bae K.T., and Heiken J.P. Scan contrast administration principles of MDCT. Eur Radiol Suppl 15 (2005) E46-E59
12. Thomsen H.S. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 181 (2003) 1463-1471
13. Grynne B.H., Nossen J.O., Bolstad B., and Borch K.W. Main results of the first comparative clinical studies on Visipaque. Acta Radiol Suppl 399 (1995) 265-270
14. Fountaine H., Harnish P., Andrew E., and Grynne B. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol 3 Suppl. 3 (1996) S475-S484
15. Speck U. X-ray contrast agents: physicochemical properties. In: Dawson P., Cosgrove D.O., and Grainger R.G. (Eds). Textbook of contrast media (1999), Isis Medical Media, Oxford, England 35-45
16. Spencer C.M., Goa K.L., and Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an X-ray contrast medium. Drugs 52 (1996) 899-927
17. Aspelin P., Stacul F., Thomsen H.S., Morcos S.K., and van der Molen A.J. Effects of iodinated contrast media on blood and endothelium. Eur Radiol (2006) 1-9
18. Webb J.A., Stacul F., Thomsen H.S., and Morcos S.K. Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13 (2003) 181-184
19. Shehadi W.H., and Toniolo G. Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology. Radiology 137 (1980) 299-302
20. McClennan B.L. Adverse reactions to iodinated contrast media. Recognition and response. Invest Radiol 29 Suppl. 1 (1994) S46-S50
21. Idee J.M., Pines E., Prigent P., and Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19 (2005) 263-281
22. Sutton A.G., Finn P., Grech E.D., et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 141 (2001) 677-683
23. Sutton A.G., Finn P., Campbell P.G., et al. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J Invasive Cardiol 15 (2003) 133-138
24. Katayama H. Survey of safety of clinical contrast media. Invest Radiol 25 Suppl. 1 (1990) S7-S10
25. Sapoval M.R., Beyssen B.M., Girardot C., et al. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate. Clin Radiol 51 (1996) 210-213
26. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
27. Kjellevand T.O., Klow N.E., Vatne K., et al. Coronary angioplasty using a low osmolar nonionic contrast medium. A retrospective angiographic and clinical evaluation. Acta Radiol 36 (1995) 54-57
28. Morcos S.K., Dawson P., Pearson J.D., et al. The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol 29 (1998) 31-46
29. Baath I. Contrast agents and the cardiovascular system. In: Dawson P., Cosgrove D., and Grainger R. (Eds). Textbook of contrast media (1999), Isis Medical Media Ltd., Oxford
30. Choi H.S., Choi B.W., Choe K.O., et al. Pitfalls, artifacts, and remedies in multi-detector row CT coronary angiography. Radiographics 24 (2004) 787-800
31. McClennan B.L., and Stolberg H.O. Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin North Am 29 (1991) 437-454
32. Flinck A., and Selin K. Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate. Int J Cardiol 76 (2000) 173-180
33. Flinck A., Selin K., Bjorneld L., and Nossen J.O. Iodixanol and iohexol in cardioangiography. A comparative vectorcardiographic study. Acta Radiol 41 (2000) 384-389
34. Pugh N.D. Haemodynamic and rheological effects of contrast media: the role of viscosity and osmolality. Eur Radiol 6 Suppl. 2 (1996) S13-S15
35. Corot C., Chronos N., and Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagul Fibrinolysis 7 (1996) 602-608
36. Zhang H., Holt C.M., Malik N., Shepherd L., and Morcos S.K. Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol 73 (2000) 1034-1041
37. Barstad R.M., Buchmann M.S., Hamers M.J., et al. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation. Acta Radiol 37 (1996) 954-961
38. Davidson C.J., Mark D.B., Pieper K.S., et al. Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8517 patients. Am J Cardiol 65 (1990) 1481-1484
39. Bertrand M.E., Esplugas E., Piessens J., and Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty VIP Trial Investigators. Circulation 101 (2000) 131-136
40. Davidson C.J., Laskey W.K., Hermiller J.B., et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 101 (2000) 2172-2177
41. Speck U., Siefert H.M., and Klink G. Contrast media and pain in peripheral arteriography. Invest Radiol 15 (1980) S335-S339
42. Lee Jr. F.T., Caroline D.F., Thornbury J.R., et al. A randomized comparison of iodixanol and iohexol in adult body computed tomography scanning. Acad Radiol 3 Suppl. 3 (1996) S500-S506
43. Grossman R.I., and Modic M.T. A randomized comparison of iodixanol and iohexol in adult intracranial computed tomography scanning. Acad Radiol 3 Suppl. 3 (1996) S488-S494
44. Fischbach R., Landwehr P., Svaland M., et al. Spiral CT angiography of the abdominal aorta. Comparison of iodixanol and ioversol. Invest Radiol 34 (1999) 374-380
45. Doerfler A., Fiebach J., Wanke I., Forsting M., Henseke P., and Sartor K. Iodixanol in cerebral computed tomography: a randomized, double-blind, phase-III, parallel study with iodixanol and iohexol. Eur Radiol 9 (1999) 1362-1365
46. Rienmuller R., Brekke O., Kampenes V.B., and Reiter U. Dimeric versus monomeric nonionic contrast agents in visualization of coronary arteries. Eur J Radiol 38 (2001) 173-178
47. Bellin M.F., Jakobsen J.A., Tomassin I., et al. Contrast medium extravasation injury: guidelines for prevention and management. Eur Radiol 12 (2002) 2807-2812
48. Cohan R.H., Bullard M.A., Ellis J.H., et al. Local reactions after injection of iodinated contrast material: detection, management, and outcome. Acad Radiol 4 (1997) 711-718
49. Thomsen H.S. How to avoid CIN: guidelines from the European Society of Urogenital Radiology. Nephrol Dial Transplant 20 Suppl. 1 (2005) i18-i22
50. Cohan R.H., Ellis J.H., and Garner W.L. Extravasation of radiographic contrast material: recognition, prevention, and treatment. Radiology 200 (1996) 593-604
51. Wysowski D.K., and Nourjah P. Deaths attributed to X-ray contrast media on U.S. death certificates. AJR Am J Roentgenol 186 (2006) 613-615
52. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
53. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
54. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
55. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
56. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365
57. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol 28 Suppl. 2 (2005) S3-S11
58. McCullough P.A. Beyond serum creatinine: defining the patient with renal insufficiency and why?. Rev Cardiovasc Med 4 Suppl. 1 (2003) S2-S6
59. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9 (1999) 1602-1613
60. Manske C.L., Sprafka J.M., Strony J.T., and Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (1990) 615-620
61. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
62. Iakovou I., Dangas G., Mehran R., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 15 (2003) 18-22
63. Jakobsen J.A. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol Suppl 399 (1995) 191-195
64. Persson P.B., Hansell P., and Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68 (2005) 14-22
65. Berg K.J., and Jakobsen J.A. Renal tolerance of nonionic dimers in humans: how relevant are experiments in rats?. Invest Radiol 32 (1997) 368-370
66. Ueda J., Nygren A., Hansell P., and Erikson U. Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 33 (1992) 596-599
67. Ueda J., Nygren A., Hansell P., and Ulfendahl H.R. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 34 (1993) 83-87
68. Jakobsen J.A., Lundby B., Kristoffersen D.T., Borch K.W., Hald J.K., and Berg K.J. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 182 (1992) 419-424
69. Aspelin P., Aubry P., Fransson S.G., Strasser R., Willenbrock R., and Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
70. Murakami R., Tajima H., Kumazaki T., and Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate. Acta Radiol 39 (1998) 368-371
71. Jakobsen J.A., Nossen J.O., Jorgensen N.P., and Berg K.J. Renal tubular effects of diuretics and X-ray contrast media. A comparative study of equimolar doses in healthy volunteers. Invest Radiol 28 (1993) 319-324
72. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
73. Chalmers N., and Jackson R.W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 72 (1999) 701-703
74. Jo S.H., Youn T.J., Koo B.K., et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 924-930
75. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared to low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
76. Carrington C. Fast CT prompts new look at contrast techniques. Diagnostic Imaging, available at: ; 2007 [accessed January 17, 2007].
77. Blomley M.J., and Dawson P. Bolus dynamics: theoretical and experimental aspects. Br J Radiol 70 (1997) 351-359
78. Cademartiri F., van der Lugt A., Luccichenti G., Pavone P., and Krestin G.P. Parameters affecting bolus geometry in CTA: a review. J Comput Assist Tomogr 26 (2002) 598-607
79. Fleischmann D. Use of high concentration contrast media: principles and rationale-vascular district. Eur J Radiol 45 Suppl. 1 (2003) S88-S93
80. Fishman E.K. Multidetector-row computed tomography to detect coronary artery disease: the importance of heart rate. Eur Heart J Suppl 7 (2005) G4-G12
81. Bédard J.P., Blais C., Patenaude Y.G., and Monga E. Pulmonary embolism: prospective comparison of iso-osmolar and low-osmolarity nonionic contrast agents for contrast enhancement at CT angiography. Radiology 234 (2005) 929-933
82. Cademartiri F., Runza G., Mollet N.R., et al. Impact of intravascular enhancement, heart rate, and calcium score on diagnostic accuracy in multislice computed tomography coronary angiography. Radiol Med (Torino) 110 (2005) 42-51
83. Michel S.J., Fried A.M., Sinha S., et al. Comparison of iodixanol with iohexol for delayed pelvic venous opacification: a preliminary study of potential use for CT venography. AJR Am J Roentgenol 183 (2004) 123-126
84. Baron R.L., and Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127 (2004) S133-S143
85. Francis I.R., Cohan R.H., McNulty N.J., et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 180 (2003) 1217-1224
86. Brink J.A. Contrast optimization and scan timing for single and multidetector-row computed tomography. J Comput Assist Tomogr 27 Suppl. 1 (2003) S3-S8
87. Fenchel S., Fleiter T.R., Aschoff A.J., van Gessel R., Brambs H.J., and Merkle E.M. Effect of iodine concentration of contrast media on contrast enhancement in multislice CT of the pancreas. Br J Radiol 77 (2004) 821-830
88. Graf O., Gazelle G.S., Kreuzer S., et al. Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: comparison of iodixanol and iopromide. Am J Roentgenol 168 (1997) 213-217
89. Rasmussen F., Lindequist S., Nielsen S.M., and Bjartveit K. Renal CT after intravenous injection of nonionic dimeric or nonionic monomeric contrast media in healthy volunteers. Acta Radiol 38 (1997) 61-67
90. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
91. Lufft V., Hoogestraat-Lufft L., Fels L.M., et al. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 40 (2002) 236-242
92. Garcia-Ruiz C., Martinez-Vea A., Sempere T., et al. Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydratation [sic]. Clin Nephrol 61 (2004) 170-176
93. Becker C.R., and Reiser M.F. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 40 (2005) 672-675
94. Josephson S.A., Dillon W.P., and Smith W.S. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 64 (2005) 1805-1806
95. Polena S., Yang S., Alam R., et al. Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacol Soc 48 (2005) 134-135
96. Thomsen H.S., and Morcos S.K. ESUR guidelines on contrast media. Abdom Imaging 31 (2006) 131-140
97. Pannu N., Manns B., Lee H., and Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65 (2004) 1366-1374
98. Kshirsagar A.V., Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15 (2004) 761-769
99. Fishbane S., Durham J.H., Marzo K., and Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15 (2004) 251-260